IPO Boutique

Healthcare Royalty, Inc IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Healthcare Royalty, Inc, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Healthcare Royalty, IncHCRX -
NASDAQ
Postponed $0.00 $0.00Postponed8/6/2021
Goldman Sachs, Citigroup, Credit Suisse, Jefferies, Cowen, SVB Leerink
Co-Manager(s):
Truist Securities, BMO Capital Markets, Stifel, Raymond James, Siebert Williams Shank, Cabrera Capital Markets, Drexel Hamilton
Health Care
Filing(s):

Filed 2021-07-01
Terms Added 2021-07-29



About Healthcare Royalty, Inc (adapted from Healthcare Royalty, Inc prospectus):
They are the leading mid-market royalty acquisition company, based upon the number of transactions and aggregate value of capital deployed since 2016.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "HCRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved